Vinayak Bapat

Showing 1-19 of 19 articles

Reference dimensions of stented surgical aortic bioprostheses for valve size determination

Anastasius M, Godoy M, Weir-McCall J, Bapat V, Sathananthan J, Hensey M, Sellers S, Cheung A, Ye J, Wood D, Leipsic J, Webb J, Blanke P

August 7, 2020 | 10.4244/EIJ-D-19-00921

Interventions for valvular disease

Reference dimensions to determine valve size of stented surgical aortic bioprostheses by computed tomography

Anastasius M, Godoy M, Weir-McCall J, Bapat V, Sathananthan J, Hensey M, Sellers S, Cheung A, Ye J, Wood D, Leipsic J, Webb J, Blanke P

February 4, 2020 | 10.4244/EIJ-D-19-00921

Interventions for valvular disease

Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

Seiffert M, Treede H, Schofer J, Linke A, Wöhrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Mueller O, Whisenant B, Thukkani A, Weisz G, Dvir D

July 20, 2018 | 10.4244/EIJ-D-17-00546

Interventions for valvular disease

Transcatheter mitral valve replacement: device landscape and early results

Patel A, Bapat V

September 24, 2017 | 10.4244/EIJ-D-17-00673

Interventions for valvular disease

Early experience with the Occlutech PLD occluder for mitral paravalvar leak closure through a hybrid transapical approach

Bedair R, Morgan G, Bapat V, Kapetanakis S, Goreczny S, Simpson J, Qureshi S

December 9, 2016 | 10.4244/EIJY15M12_07

Interventions for valvular disease

Intrepid transcatheter mitral valve replacement system: technical and product description

Meredith I, Bapat V, Morriss J, McLean M, Prendergast B

September 18, 2016 | 10.4244/EIJV12SYA21

Interventions for valvular disease

The new “tenth commandment”?

Bapat V

July 20, 2016 | 10.4244/EIJV12I4A74

Interventions for valvular disease

Transaortic transcatheter aortic valve implantation using the Lotus valve: first-in-man experience

Bapat V, Asrress K, Boix R, Lim Z, Hancock J, Redwood S

June 20, 2016 | 10.4244/EIJY15M11_03

Interventions for valvular disease

Mitral valve-in-ring: the good, the bad, and the ugly

Bapat V

February 19, 2016 | 10.4244/EIJV11I10A221

Interventions for valvular disease

In vitro evaluation of valve-in-valve combinations using a SAPIEN XT valve implanted within PERIMOUNT and Magna Ease pericardial bioprostheses

Bapat V, Chambers D

February 12, 2016 | 10.4244/EIJV11I11A251

Interventions for valvular disease

The Edwards Fortis transcatheter mitral valve implantation system

Bapat V, Lim Z, Boix R, Pirone F

September 17, 2015 | 10.4244/EIJV11SWA21

The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

Khawaja M, Asrress K, Haran H, Arri S, Nadra I, Bolter K, Wilson K, Clack L, Hancock J, Young C, Bapat V, Thomas M, Redwood S

August 20, 2015 | 10.4244/EIJY14M05_09

Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches

Bona V, Khawaja M, Bapat V, Young C, Hancock J, Redwood S, Fusari M, Thomas M

June 19, 2015 | 10.4244/EIJV11I2A41

Transcatheter valve-in-valve implantation for failing prosthetic valves

Bapat V, Asrress K

December 22, 2014 | 10.4244/EIJV10I8A155

Valve-in-valve apps: why and how they were developed and how to use them

Bapat V

September 27, 2014 | 10.4244/EIJV10SUA7

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M

September 27, 2014 | 10.4244/EIJV10SUA18

Direct TAVI using a balloon-expandable system: a novel technique to eliminate pre-deployment balloon aortic valvuloplasty

Davies W, Bapat V, Hancock J, Young C, Redwood S, Thomas M

June 20, 2014 | 10.4244/EIJV10I2A40

Transaortic access is the key to success

Bapat V, Bruschi G

September 15, 2013 | 10.4244/EIJV9SSA6

The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

Khawaja M, Thomas M, Joshi A, Asrress K, Wilson K, Bolter K, Young C, Hancock J, Bapat V, Redwood S

September 28, 2012 | 10.4244/EIJV8I5A87

Latest news

NEW ISSUE

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

August 7, 2020

NEW

Ahead of Print: Coronary Artery Thrombosis in COVID-19

August 7, 2020

Editorial

Coronary collaterals, the natural grafts of CTO lesions

C. Di Mario

August 7, 2020

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

August 5, 2020

Guidance Papers

Guidelines, consensus & position papers

June 25, 2020

Editorial

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

August 7, 2020

JAA

This Week's JAA's: Real-world Use of the Evolut PRO Valve...